During the past decade, The Hospital of Hyogo College of Medicine conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 23 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 12 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Hospital of Hyogo College of Medicine" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Pfizer" with 8 trials sponsored, "Takeda" with 6 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Celgene" with 5 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Hospital of Hyogo College of Medicine" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "Asahi Kasei Medical Co., Ltd." with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "The Hospital of Hyogo College of Medicine" are "Crohn's Disease" (7 trials), "Ulcerative Colitis" (5 trials), "Colitis, Ulcerative" (3 trials), "Breast Cancer" (2 trials) and "Eosinophilic Esophagitis" (2 trials). Many other conditions were trialed in "The Hospital of Hyogo College of Medicine" in a lesser frequency.

Most popular intervention types in "The Hospital of Hyogo College of Medicine" are "Drug" (46 trials), "Biological" (8 trials), "Other" (5 trials), "Device" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "CP-690,550" (5 trials), "Guselkumab" (5 trials), "Paclitaxel" (4 trials) and "Dexamethasone" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Hospital of Hyogo College of Medicine" are 55 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Hospital of Hyogo College of Medicine". undefined are not yet recruiting, 15 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in The Hospital of Hyogo College of Medicine, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Hospital of Hyogo College of Medicine, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".